Background/aims: Despite several decades of research into the effects of caffeine on EEG, few consistent findings have emerged. Notwithstanding the likelihood that differences in methodology may explain some of the inconsistency, confidence in the published findings is undermined by the failure in previous studies to control for the effects of caffeine withdrawal and withdrawal reversal.
Methods: Participants (n = 22) alternated weekly between ingesting placebo and caffeine (1.75 mg/kg) 3 times daily for 4 consecutive weeks. EEG activity was measured at 32 sites during eyes closed, eyes open, and performance of a vigilance task.
Results: Caffeine was found to have few and modest effects on EEG in the theta and alpha bandwidths, and no effects in the delta and beta bandwidths. Evidence was found of withdrawal, withdrawal reversal, and tolerance in relation to observed increases in theta power during task performance; withdrawal and withdrawal reversal in relation to increases in alpha power during all three behavioural conditions (eyes closed, eyes open, and task performance), and withdrawal-induced adverse effects in relation to aspects of subjective mood.
Conclusion: The finding of similar increases in theta power following caffeine challenge and acute caffeine withdrawal casts doubt on whether caffeine may be viewed as having direct stimulant effects. Results could suggest that change in drug state, whether in the form of acute caffeine withdrawal or challenge, may be disruptive to electrophysiological activity in the brain.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000120625 | DOI Listing |
Annu Rev Clin Psychol
January 2025
Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; email:
The opioid crisis, driven by illicitly manufactured fentanyl, presents significant challenges in treating opioid use disorder (OUD) and opioid withdrawal syndrome. Fentanyl is uniquely lethal due to its rapid onset and respiratory depressant effects, driving the surge in overdose deaths. This review examines the limitations of traditional diagnostic criteria like those of the , Fifth Edition, Text Revision (DSM-5-TR) and explores the potential of dimensional models such as the Hierarchical Taxonomy of Psychopathology (HiTOP) for a more nuanced understanding of OUD.
View Article and Find Full Text PDFThe COVID-19 pandemic instigated changes in almost all aspects of youth's life. While numerous studies have been implemented to understand how these changes are related to youth's development, few concerned large representative samples. This study introduces the methodology and initial results of the Quebec (Canada) Resilience Project (QRP), a representative longitudinal study.
View Article and Find Full Text PDFAnn Indian Acad Neurol
January 2025
Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
"Tardive syndrome" is an umbrella term for a group of drug-induced movement disorders associated with the prolonged use of mainly dopamine receptor blockers and also other medications. Early recognition followed by gradual withdrawal of the incriminating drug may lead to reversal, although not in all patients. Tardive syndromes are usually mixed movement disorders, with specific phenotypes, which may lead to severe disability.
View Article and Find Full Text PDFEur J Neurol
February 2025
Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Background And Purpose: Up to 80% of patients diagnosed with reversible cerebral vasoconstriction syndrome (RCVS) experience complications such as ischaemic stroke, intracerebral or subarachnoid haemorrhage or posterior reversible encephalopathy syndrome. The aim was to evaluate the incidence of complications in patients diagnosed with RCVS in our clinic.
Patients And Methods: All adult patients (age >16 years) diagnosed with RCVS at the Helsinki University Central Hospital during the period between 1 January 2016 and 31 December 2022 were retrospectively identified.
J Pestic Sci
November 2024
Graduate School of Agriculture, Ehime University.
The enantiospecific anti-phytopathogenic fungal activity of a new type of coumarin bearing a phenylpropanoid unit at the 3-position was found. ()-3-[1-Methoxy-3-(4-methoxyphenyl)prop-2-yl]coumarin (()-: EC=16.5 µM) was 30 times more effective than the ()-form against the Japanese pear pathotype.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!